影像放射

订阅

MedSci主页 / 所有栏目 / 影像放射

Clin Chem：回旋共振质谱法和串联质谱法诊断血红蛋白病和β地中海贫血症

2019-10-19 gladiator MedSci原创

血红蛋白病β地中海贫血症
关注

血红蛋白病和地中海贫血是最常见的遗传疾病。目前筛查方法主要有阳离子交换高效液相色谱法和电泳法，但由于这类方法分辨率有限，结果可能不是很明确。因此，在随后还需要进行复杂的基因检测以进行确认。

血红蛋白病和地中海贫血是最常见的遗传疾病。目前筛查方法主要有阳离子交换高效液相色谱法和电泳法，但由于这类方法分辨率有限，结果可能不是很明确。因此，在随后还需要进行复杂的基因检测以进行确认。

williamhill asia 进行了一个超高质量的准确性，和广泛的残余物的裂解的快速数据采集(3分钟)串联质谱分析(MS / MS)，通过使用正离子21特斯拉傅立叶变换离子回旋共振 - 串联质谱法（21ŤFT-ICR MS / MS）对血红蛋白（Hb）的变体的从头测序以及β地中海贫血的诊断。

williamhill asia 在18个样本的盲法分析中正确地识别了所有的Hb变异，包括首次对纯合子Hb Himeji变异的鉴定。此外，在前体离子质谱(MS1)和产物离子质谱(MS2)中均解决了一个同位素质量间距为0.0194 Da (Hb AD)的Hb杂合变异体。在盲法分析中，williamhill asia 还观察到δ和β亚基（δ/β）或δ和α亚基（δ/α）之间的丰度比可以用来诊断性状由1个HBB基因所引起的突变β地中海贫血。

研究表明，21 T FT-ICR MS/MS为血Hb严格的MS/MS分析提供了一个基准。目前的方法有可能被转换到低分辨率质谱仪(低FT-ICR质谱和Orbitrap) Hb变异分析(MS1 和MS2)和β-thalassemia诊断(MS1)。

原始出处：

Lidong He, Alan L. Rockwood,Diagnosis of Hemoglobinopathy and β-Thalassemia by 21 Tesla Fourier Transform Ion Cyclotron Resonance Mass Spectrometry and Tandem Mass Spectrometry of Hemoglobin from Blood

本文系williamhill asia 医学（MedSci）原创编译整理，转载需授权！


版权声明：
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于williamhill asia 医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章，或“williamhill asia 号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系，williamhill asia 将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1776814, encodeId=d2a01e76814db, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Wed Jan 29 03:27:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441441, encodeId=ff661441441af, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19230, encryptionId=aebc192307c, topicName=β地中海贫血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32454837595, createdName=ms7258648636991762, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469858, encodeId=89a514698585a, content=<a href='/topic/show?id=0ba5898e837' target=_blank style='color:#2F92EE;'>#血红蛋白病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89878, encryptionId=0ba5898e837, topicName=血红蛋白病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac2f7082167, createdName=jmtang, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553369, encodeId=f1ca15533692f, content=<a href='/topic/show?id=81bd923e559' target=_blank style='color:#2F92EE;'>#质谱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92375, encryptionId=81bd923e559, topicName=质谱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96fd14366106, createdName=jeanqiuqiu, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575506, encodeId=d6f415e55064c, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=)]
    2020-01-29 medscijoin

    #贫血症#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1776814, encodeId=d2a01e76814db, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Wed Jan 29 03:27:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441441, encodeId=ff661441441af, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19230, encryptionId=aebc192307c, topicName=β地中海贫血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32454837595, createdName=ms7258648636991762, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469858, encodeId=89a514698585a, content=<a href='/topic/show?id=0ba5898e837' target=_blank style='color:#2F92EE;'>#血红蛋白病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89878, encryptionId=0ba5898e837, topicName=血红蛋白病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac2f7082167, createdName=jmtang, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553369, encodeId=f1ca15533692f, content=<a href='/topic/show?id=81bd923e559' target=_blank style='color:#2F92EE;'>#质谱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92375, encryptionId=81bd923e559, topicName=质谱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96fd14366106, createdName=jeanqiuqiu, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575506, encodeId=d6f415e55064c, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=)]
    2019-10-21 ms7258648636991762

    #β地中海贫血#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1776814, encodeId=d2a01e76814db, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Wed Jan 29 03:27:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441441, encodeId=ff661441441af, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19230, encryptionId=aebc192307c, topicName=β地中海贫血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32454837595, createdName=ms7258648636991762, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469858, encodeId=89a514698585a, content=<a href='/topic/show?id=0ba5898e837' target=_blank style='color:#2F92EE;'>#血红蛋白病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89878, encryptionId=0ba5898e837, topicName=血红蛋白病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac2f7082167, createdName=jmtang, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553369, encodeId=f1ca15533692f, content=<a href='/topic/show?id=81bd923e559' target=_blank style='color:#2F92EE;'>#质谱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92375, encryptionId=81bd923e559, topicName=质谱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96fd14366106, createdName=jeanqiuqiu, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575506, encodeId=d6f415e55064c, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=)]
    2019-10-21 jmtang

    #血红蛋白病#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1776814, encodeId=d2a01e76814db, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Wed Jan 29 03:27:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441441, encodeId=ff661441441af, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19230, encryptionId=aebc192307c, topicName=β地中海贫血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32454837595, createdName=ms7258648636991762, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469858, encodeId=89a514698585a, content=<a href='/topic/show?id=0ba5898e837' target=_blank style='color:#2F92EE;'>#血红蛋白病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89878, encryptionId=0ba5898e837, topicName=血红蛋白病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac2f7082167, createdName=jmtang, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553369, encodeId=f1ca15533692f, content=<a href='/topic/show?id=81bd923e559' target=_blank style='color:#2F92EE;'>#质谱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92375, encryptionId=81bd923e559, topicName=质谱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96fd14366106, createdName=jeanqiuqiu, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575506, encodeId=d6f415e55064c, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=)]
    2019-10-21 jeanqiuqiu

    #质谱#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1776814, encodeId=d2a01e76814db, content=<a href='/topic/show?id=5b989244667' target=_blank style='color:#2F92EE;'>#贫血症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92446, encryptionId=5b989244667, topicName=贫血症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81a339030187, createdName=medscijoin, createdTime=Wed Jan 29 03:27:00 CST 2020, time=2020-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441441, encodeId=ff661441441af, content=<a href='/topic/show?id=aebc192307c' target=_blank style='color:#2F92EE;'>#β地中海贫血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19230, encryptionId=aebc192307c, topicName=β地中海贫血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32454837595, createdName=ms7258648636991762, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469858, encodeId=89a514698585a, content=<a href='/topic/show?id=0ba5898e837' target=_blank style='color:#2F92EE;'>#血红蛋白病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89878, encryptionId=0ba5898e837, topicName=血红蛋白病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ac2f7082167, createdName=jmtang, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553369, encodeId=f1ca15533692f, content=<a href='/topic/show?id=81bd923e559' target=_blank style='color:#2F92EE;'>#质谱#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92375, encryptionId=81bd923e559, topicName=质谱)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96fd14366106, createdName=jeanqiuqiu, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575506, encodeId=d6f415e55064c, content=<a href='/topic/show?id=cd9941326bc' target=_blank style='color:#2F92EE;'>#地中海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41326, encryptionId=cd9941326bc, topicName=地中海)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303116130321, createdName=wgx311, createdTime=Mon Oct 21 02:27:00 CST 2019, time=2019-10-21, status=1, ipAttribution=)]
    2019-10-21 wgx311

    #地中海#

    0

相关威廉亚洲官网

异常血红蛋白病的围术期麻醉处理1例

患者，女，24岁，因反复右耳前皮肤红肿5个月余入院，入院诊断为先天性耳前瘘管（右），拟全身麻醉下行右耳前瘘管切除术。患者既往体健，否认心肺疾病史及手术外伤史。术前检查：胸部Ｘ线片、心电图及三大常规、血生化、凝血五项等实验室检查结果均正常。术前麻醉访视时发现患者皮肤、口唇及甲床呈现明显紫绀，但指端皮温正常，无杵状指，心肺腹查体未见异常。患者诉其皮肤、口唇、甲床一直呈青紫色，但未感不适。

Blood：如何管理血红蛋白病/溶血性疾病患者的缺氧？

血红蛋白病是由基因突变导致的，其血红蛋白分子异常导致溶血性贫血。慢性并发症包括肺实变、心血管功能异常影响气体交换导致组织缺氧。低氧，即到达身体组织的氧气量不足，在血红蛋白病患者中普遍存在，其原因常是多因素的。血红蛋白病慢性缺氧是疾病严重程度的标志，与发病率和死亡率增加相关。因而，深入了解低氧在该病理过程中的发病机制对合理治疗潜在的病因和预防并发症至关重要。Evans M. Machogu和Robe

Blood：HCT-CI评分可预测非恶性血液病患者进行造血细胞移植后的死亡风险

中心点：HCT-CI评分≥3分与非恶性疾病进行同种异体移植后的低存活率相关。HCT-CI评分不能预测血红蛋白病患者移植后的死亡率风险。摘要：虽然总体存活率提高，但非恶性疾病进行同种异体造血细胞移植（HCT）后的死亡率仍是一个严峻的问题。由HCT共病指数（HCT-CI）所评估的HCT前的情况是否能预测这类患者移植后存活的可能性？Monica Thakar等人对此进行研究。通过国际血液和骨髓移植研究中